Exploring Providers' Behaviors, Attitudes, and Preferences on the Treatment of Pulmonary Arterial Hypertension With Endothelin Receptor Antagonist (ERA) + Phosphodiesterase-5 Inhibitors (PDE5i). [PDF]
Pulm CircKolaitis NA +10 more
europepmc +1 more source
Covid-19-induced pulmonary hypertension in children, and the use of phosphodiesterase-5 inhibitors. [PDF]
F1000Res, 2021 Dimiati H, Umara DA, Naufal I.
europepmc +1 more source
Phosphodiesterase-5 inhibitors for colon cancer chemoprevention
Aging, 2018 Islam, Bianca N., Browning, Darren D.
openaire +2 more sources
Epilepsia, EarlyView.Abstract Objective Accumulating evidence indicates that aberrant C1q‐C3 complement signaling in microglia and astrocytes drives synaptic dysfunction and neuronal loss. C1q‐mediated synaptic dysfunction disrupts neuronal circuitry balance and can lead to network hyperexcitability in epilepsy.
Yoonyi Jeong +5 more
wiley +1 more source
Anti-infection mechanism of phosphodiesterase-5 inhibitors and their roles in coronavirus disease 2019 (Review). [PDF]
Exp Ther Med, 2021 Su H, Ma C, Li H.
europepmc +1 more source
MP80-01 PHOSPHODIESTERASE TYPE 5 INHIBITOR USE IS NOT ASSOCIATED WITH BIOCHEMICAL RECURRENCE AFTER DEFINITIVE THERAPY FOR PROSTATE CANCER [PDF]
, 2016 Michael Leapman +6 more
openalex +1 more source
The FEBS Journal, EarlyView.The regulatory subunit RIβ of protein kinase A occurs in two variants that differ at residue 268 (A268 versus R268). This seemingly small substitution significantly changes cAMP sensitivity, basal kinase activity, and the dynamic behavior of the regulatory domains.
Maximilian Wallbott +6 more
wiley +1 more source
Discovery of Natural Phosphodiesterase 5 Inhibitors from <i>Dalbergia cochinchinensis</i> Pierre Leaves Using LC-QTOF-MS<sup>2</sup>. [PDF]
Plants (Basel)Chantakul R +5 more
europepmc +1 more source